Product image of Cometriq (Cabozantinib) supplied by GNH India

Cometriq

Active Ingredient:
Cabozantinib
Origin:
EU

Cometriq (Cabozantinib)

Cometriq (Cabozantinib) is an oral medication used to manage certain types of cancer. This pharmaceutical is designed to target specific proteins involved in tumor growth and spread.

Manufacturer / TM Owner

Ipsen Pharma

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Cometriq is primarily used in the treatment of advanced thyroid cancer and renal cell carcinoma. It works by inhibiting the activity of proteins that promote cancer cell growth and metastasis. Patients often wonder, 'What is Cometriq used for?' This medication is typically prescribed for conditions where other treatments have proven ineffective.

Side Effects

  • Common effects of Cometriq may include fatigue, diarrhea, and decreased appetite. Some users also experience nausea, vomiting, and high blood pressure. These effects can vary in severity and may require monitoring by a healthcare professional.

Precautions & Warnings

  • Cometriq should be handled with care, as it is a potent medication. It is important to follow the prescribed dosage and administration instructions provided by a healthcare provider. Patients should also be aware of potential interactions with other medications and inform their doctor of any existing health conditions.

Avoid Interactions

  • Cometriq may interact with certain medications, including those that affect liver enzymes. It is advisable to avoid grapefruit and grapefruit juice, as they can increase the risk of side effects. Always consult a healthcare provider before starting or stopping any medication while taking Cometriq.

Frequently Asked Questions

Cometriq is used to treat advanced thyroid cancer and renal cell carcinoma, particularly when other treatments have not been effective.

Cometriq is taken orally, typically once daily. The exact dosage and administration instructions should be provided by a healthcare professional.

Common side effects include fatigue, diarrhea, decreased appetite, nausea, vomiting, and high blood pressure.

Cometriq may interact with other medications, especially those that affect liver enzymes. Always consult a healthcare provider before combining medications.

The safety of long-term use of Cometriq should be discussed with a healthcare provider, as it depends on individual health conditions and treatment responses.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Cabozantinib

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT